Novo Nordisk injects $4.1bn into latest US drug factory
Danish drugmaker Novo Nordisk, the firm behind the highly sought-after diabetes treatment Ozempic and obesity treatment Wegovy, will spend $4.1bn on a new factory in North Carolina. The 1.4 million-sq-ft…